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Abstract 
We assessed the potential of Calcium (Ca) isotope fractionation measurements in blood 
(δ
44/42
CaBlood) and urine (δ
44/42
CaUrine) as a new biomarker for the diagnosis of osteoporosis. 
One hundred post-menopausal women aged 50 to 75 years underwent dual-energy X-ray 
absorptiometry (DXA), the gold standard for determination of bone mineral density. After 
exclusion of women with kidney failure and vitamin D deficiency (<25 nmol/l) 80 women 
remained in the study. Of these women 14 fulfilled the standard diagnostic criteria for 
osteoporosis based on DXA. Both the δ
44/42
CaBlood (p<0.001) and δ
44/42
CaUrine (p=0.004) values 
were significantly different in women with osteoporosis (δ
44/42
CaBlood: -0.99±0.10 ‰, δ
 
44/42
CaUrine: +0.10±0.21 ‰, (Mean ± one standard deviation (SD) n=14) from those without 
osteoporosis (δ
44/42
CaBlood: -0.84±0.14 ‰, δ
44/42
CaUrine: +0.35±0.33 ‰, (SD), n=66). This 
corresponded to the average Ca concentrations in morning spot urine samples ([Ca]Urine) 
which were higher (p=0.041) in those women suffering from osteoporosis ([Ca]Urine-Osteoporosis: 
2.58±1.26 mmol/l, (SD), n=14) than in the control group ([Ca]Urine-Control: 1.96±1.39 mmol/l, 
(SD), n=66). However, blood Ca concentrations were statistically indistinguishable between 
groups ([Ca]Blood, control: 2.39±0.10 mmol/l (SD, n=66); osteoporosis group: 2.43±0.10 mmol/l 
(SD, n=14) and were also not correlated to their corresponding Ca isotope compositions. The 
δ
44/42
CaBlood and δ
44/42
CaUrine values correlated significantly (p=0.004 to p=0.031) with their 
corresponding DXA data indicating that both Ca isotope ratios are biomarkers for 
osteoporosis. Furthermore, Ca isotope ratios were significantly correlated to other clinical 
parameters ([Ca]Urine, ([Ca]Urine/Creatinine)) and biomarkers (CRP, CTX/P1NP) associated with 
bone mineralization and demineralization. From regression analysis it can be shown that the 
δ
44/42
CaBlood values are the best biomarker for osteoporosis and that no other clinical 
parameters need to be taken into account in order to improve diagnosis. Cut-off values for 
discrimination of subjects suffering from osteoporosis were -0.85 ‰ and 0.16 ‰ for 
δ
44/42
CaBlood and δ
44/42
CaUrine, respectively. Corresponding sensitivities were 100 % for 
δ
44/42
CaBlood and 79 % for δ
44/42
CaUrine. Apparent specificities were 55 % for δ
44/42
CaBlood and 
71 %. The apparent discrepancy in the number of diagnosed cases is reconciled by the 
different methodological approaches to diagnose osteoporosis. DXA reflects the bone mass 
density (BMD) of selected bones only (femur and spine) whereas the Ca isotope biomarker 
reflects bone Ca loss of the whole skeleton. In addition, the close correlation between Ca 
isotopes and biomarkers of bone demineralization suggest that early changes in bone 
demineralization are detected by Ca isotope values, long before radiological changes in BMD 
can manifest on DXA. Further studies are required to independently confirm that Ca isotope 
measurement provide a sensitive, non-invasive and radiation-free method for the diagnosis of 
osteoporosis. 
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Introduction 
Calcium is an essential mineral in the body, controlling the formation and maintenance of 
bones and teeth [1], muscle contraction, neural signal transmission, cell apoptosis and the 
coagulation of blood. Calcium homeostasis is carefully regulated through hormonal feedback 
loops in order to keep blood Ca levels within a narrow therapeutic range [2]. Essentially, three 
organs control the Ca homeostasis: the gastrointestinal tract (GI), where Ca is absorbed from 
the diet, the skeleton which is the main Ca reservoir, and the kidneys where Ca is reabsorbed 
from the urine back into the blood and controlled amounts are excreted. Physiological ageing 
processes as well as intestinal, bone, kidney and endocrine disorders interfere with Ca 
homeostasis. Osteoporosis, osteomalacia and rickets and renal osteodystrophy are examples 
of bone disorders linked to an impaired Ca metabolism. Osteoporosis is the most widely 
prevalent condition, mainly affecting postmenopausal women. It is a systemic disorder 
characterized by low bone mineral density (BMD), increased fragility and predisposition to 
fractures [3]. In clinical practice osteoporosis is diagnosed when BMD is reduced on DXA, 
after exclusion of other causes [3], [4]. 
Changes in BMD are associated with a net loss of Ca from the bone. This has been 
investigated by tracer experiments using stable (non-radioactive) Ca isotopes that are 
naturally present in the environment such as 
42
Ca and 
44
Ca ([5], [6]) as well as radioactive Ca 
isotopes with different half-lives (
41
Ca, 
45
Ca or 
47
Ca) [5], [6], [7], [8], [9], [10], [11]. Tracer 
studies have been carried out by the simultaneous administration of tracer enriched Ca orally 
and intravenously. However these experiments are expensive, require a ‘metabolic cage’ like 
setting, and, in case of radioactive isotopes, are associated with harmful radiation. In contrast, 
studies using stable Ca isotopes naturally present in our diet, are much cheaper and avoid 
exposure to radioactivity ([12], [13], [14]). 
The application of natural Ca isotopes follows the principle of kinetic isotope fractionation that 
separates stable isotopes from each other as a function of their mass during unidirectional 
biochemical processes [15, 16]. As a consequence of kinetic isotope fractionation, in a chain 
of chemical reactions the lighter isotope always becomes enriched in the product. Thus, at a 
trophic level along the food chain, lighter isotopes become enriched from plants to humans. 
This is expressed as decreasing 
44
Ca/
42
Ca ratios (reported as δ
44/42
Ca) from vegetables via 
meat to humans [17], with human mother’s milk being the most enriched reservoir for light Ca 
isotopes. Similarly, in the human body δ
44/42
Ca isotope ratios decrease as a function of 
biochemical processes whereby Ca from the diet goes via the blood into the skeleton [18]. 
This means that major Ca compartments in our body, such as blood and soft tissues, bone, 
urine and feces, are well characterized with a Ca isotope “fingerprint” and can be used for 
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diagnostic purposes in order to identify distinct Ca related disorders. Different laboratories 
have quantitatively confirmed that the Ca isotope fractionation, and hence the isotope 
difference between blood and bone (Δ
44/42
CaBone-Blood = δ
44/42
CaBone - δ
44/42
CaBlood) is fairly 
constant in the order of about -0.3 ‰, in different vertebrate species including chickens, 
horses [19, 20], “Göttingen” mini-pigs [14] and humans [21], and this value is independent of 
the absolute Ca isotope values in blood and bone. 
Based on observational data in animal and human studies [14, 19, 20, 21] Ca isotopes in 
blood and urine could theoretically be used to study disturbances in bone mineral balance 
such as in osteoporosis. This is based on the principal that the blood and bone Ca isotope 
compositions are in isotopic equilibrium only differing by a constant value (Δ
44/42
CaBone-Blood = 
δ
44/42
CaBone - δ
44/42
CaBlood = -0.3 ‰) [14, 19, 20, 21]. During equilibrium between bone material 
absorption and resorption the blood Ca isotope value is not changing and the Ca . Any short 
term disturbances of the isotope equilibrium between absorption and resorption (like an 
increase in dietary Ca intake) is re-equilibrated again within a half-life of about an hour due to 
low blood Ca concentrations and the high Ca exchange rates between bone and blood. 
However, when bone resorption is persistently greater than bone absorption, as seen in 
osteoporosis, the blood Ca isotope composition is lower. When the disequilibrium between Ca 
absorption and resorption continues for days to years, the bone Ca isotope composition 
successively decreases as a function of time towards lower and lower values also reflected in 
the blood Ca isotope composition by lower and lower values. The ongoing loss of Ca then 
reflects a decrease of the BMD detectable by DXA at a certain time. Hence, a relationship 
between Ca isotope values in blood and urine to bone DXA values is predicted and may 
eventually be applied to support the diagnosis of osteoporosis. These theoretical inferences 
have not been studied in humans. 
1.0 We undertook this study to determine the feasibility and diagnostic accuracy of Ca 
isotope fractionation measured in blood and urine for the diagnosis of osteoporosis in 
post-menopausal women, comparing against their corresponding DXA values as the gold 
standard. The positive and negative predictive value of Ca isotope fractionation were 
determined and the association of δ
44/42
CaUrine and δ
44/42
CaBlood with biomarkers of bone 
resorption, (CTX; C-terminal telopeptide), bone formation (P1NP; N-terminal propeptide 
of type 1 procollagen) and inflammation (CRP; C-reactive protein)[[24], [25]), were 
studied.Methods 
The aim of this study was to investigate whether the natural Ca isotope ratios (δ
44/42
Ca) in 
urine (δ
44/42
CaUrine) and blood (δ
44/42
CaBlood) can be used to diagnose osteoporosis in 
postmenopausal women, and the diagnostic accuracy of the Ca isotope fractionation 
technique compared to the gold standard DXA scans and bone biomarkers. 
1.1 Study design 
The study design is presented in detail in Supplement 1. The study was approved and 
registered (NCT02967978) by an independent ethics committee (The Ethical Committee of the 
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Medical Council of Schleswig-Holstein, Bad Segeberg, Germany) and conducted according to 
the principles stated in the Declaration of Helsinki, the national and international guidelines of 
the “Dachverband für Osteoporose” (DVO) 2014 and the International Society of Clinical 
Densitometry (ISCD) 2015 ([22], [23]), respectively. 
Post-menopausal women aged 50 - 75 years who had at least one risk factor for osteoporosis 
by age 60 years or at least 2 risk factors by age 50 years, were invited to participate in the 
study. Women with a known fracture within the previous 3 months, those with renal failure, 
cancer, and hyperparathyroidism or on sex hormone treatment were excluded (full details 
available in Supplement 1).Women with Vitamin D deficiency (defined as 25 Hydroxy Vitamin 
D level <25 nmol/l, as per the DVO definition) were excluded. In general, the definition of 
Vitamin D deficiency lightly vary in different national and international guidelines as defined 
by IOF (International Osteoporosis Foundation) and IOM (Institute of Medicine). According to 
IOF (IOM), 25OHD levels of <20 ng/ml (<12 ng/ml) is termed as deficiency, 20–30 ng/ml (12–
20 ng/ml) as insufficiency, and levels >30 ng/ml (>20 ng/ml) as sufficiency. We have used the 
German national DVO recommendation which is in fact a mean value of IOM and IOF (<25 
ng). 
One hundred consecutive women fulfilling the above criteria were screened at the Clinical 
Research Centre (CRC), Kiel. All patients underwent a DXA scan of the lumbar spine and 
proximal femur. Women were divided into those with osteoporosis and those without 
osteoporosis according to the world health organization (WHO) definition [24]: osteoporosis 
was considered present if BMD as assessed by DXA densitometry of the lumbar spine and/or 
proximal femur (total area or femoral neck) had a T-Score ≤ -2.5,, and after excluding other 
disorders associated with a reduction in bone mineral content and osteomalacia.We based the 
recruitment on the following assumptions: according to the European Prospective 
Osteoporosis Study (EPOS) study [25] the prevalence of osteoporosis in German 
postmenopausal women aged 50 to 60 years is about 15% and about 45% at the age of more 
than 70 years. In women with risk factors such as hip fracture in father and/or mother, 
smoking, lactose intolerance, vegan diet, underweight (BMI < 20), diabetes, or long-standing 
use of loop diuretics, glucocorticoids, aromatase inhibitors and proton pump inhibitors, a 
higher prevalence is expected. Thus, by selecting women with at least one risk factor for 
osteoporosis, a higher proportion than in the general population were expected to meet the 
criteria for osteoporosis. Based on these assumptions, we expected to have at least 40% 
subjects suffering from osteoporosis. On screening 100 women, 20 women were found to 
have low vitamin D levels, renal failure or other risk factors requiring exclusion. Eighty women 
(n = 40 with risk factors for osteoporosis and n = 40 without risk factors for osteoporosis (age-
matched control group) were finally included in the study. 
1.1.1 Study investigations 
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At the first screening visit demographic details, past medical history, including risk factors for 
osteoporosis, and medication history were determined and suitable subjects consented and 
recruited. Weight and height measurements were performed and dietary intake was assessed 
using food-frequency-questionnaires (FFQ). At the second visit women were asked to bring in 
a single morning urine and fecal sample of that day, and blood sampling was performed. DXA 
of lumbar vertebrae and hip was performed within 4 weeks after visit 2. An optional visit 3 
served for informing the subjects about their findings. Further details are provided in 
Supplement 1. 
1.2 Dual X-ray absorptiometry (DXA) 
DXA of the lumbar spine and hip were performed on a Hologic QDR 4500 following 
manufacturer’s instructions and standard protocol (Supplement 1). All images were analyzed 
by observers blinded to the subjects’ clinical status. According to the WHO definition, 
osteoporosis is present when the bone density measurement is 2.5 SD below the average of 
20 - 29 year-old women (peak bone mass), also expressed as a T-score value ≤ -2.5. T-
scores between -1 and -2.5 SD are defined as reduced bone density or osteopenia. A T-score 
value of ≥-2.5 indicates significantly reduced bone density and an increased risk of bone 
fractures. In this study, the lowest T-score obtained from either vertebral spine or hip was used 
for the diagnosis of osteoporosis. Subjects in whom the DXA quality was poor due to scoliosis, 
degenerative disease or other issues were excluded from further analysis. 
1.3 Chemical Sample preparation and Mass-spectrometer Measurement 
1.3.1 Sample Digestion and Purification 
Samples were chemically treated in batches to remove all organic material before 
measurement in the mass spectrometer. Each batch consisting out of 20 samples (acidified 
prior to chemical treatment), one sample replicate, one procedural blank, one of each 
reference material (NIST SRM 915a, NIST SRM 1486, IAPSO Standard Seawater) and one of 
the in-house standards (urine AK1 or blood SERA-1). All liquid samples were homogenized by 
shaking prior to chemical preparation. About 1180 µl of acidified urine, 450 µl serum and about 
100 to 500 mg feces were used for chemical digestion. About 3 ml of 14 mol/l HNO3 and 1 ml 
of H2O2 (30%) were added to urine and feces and 3 ml of 14 mol/l HNO3 plus 100 µl HClO4 
were added to the serum samples. Blank and reference materials were always treated the 
same way. The closed beakers were placed on a hot plate at 120°C for 12 hours then opened 
and evaporated afterwards. The residues were treated with nitric acid and hydrogen peroxide, 
heated to 120 °C and evaporated, with the procedure repeated multiple times until the solution 
was colorless. Next, Ca, Magnesium (Mg) and Strontium (Sr) concentrations of the solutions 
were measured on a Q-ICP-MS Agilent 7500cx. An aliquot of the sample solution containing 
50 µg of Ca was chemically purified using an automatic purification system (prepFAST MC, 
ESI, USA). Calcium yields were in the order of or better than 95% and the Ca/Sr in the 
processed solution were > 10000. The Ca fraction collected from the original solutions was 
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dried down at 120°C and then re-dissolved in 1 ml of 14 mol/l HNO3 and 0.5 ml H2O2 (30 %). 
The solution was then heated up with closed lids for 12 h at 120°C and dried down again. 
Finally the residues were re-dissolved in 0.2 mol/l nitric acid to yield a final Ca concentration of 
about 5 µg/ml. 
1.3.2 Mass spectrometry and data evaluation 
Calcium isotope measurements were performed on a MC-ICP-MS (Neptune plus, Thermo 
Fisher Scientific, Bremen, Germany) at the mass spectrometer facilities of the GEOMAR 
Helmholtz Centre for Ocean Research Kiel, Germany. The mass spectrometer was equipped 
with nine Faraday cups of which eight are moveable. The mass spectrometer was set up to 
measure masses 42, 43, 43.5 and 44 simultaneously. In order to suppress interfering Ca- and 
Ar-hydrides (e.g. 
40
Ar
1
H2 on 
42
Ca) an APEX IR (ESI, Omaha, Nebraska, USA) sample 
introduction system was used. All measurements were performed in medium resolution (MR, 
m/Δm ~ 4,000) on the interference-free plateau of the low mass side of the peaks. This was 
achieved by choosing an appropriate center cup mass of 43.687±0.001 amu and verified on a 
daily basis (cf. [26]). Instrumental fractionation (mass bias) was corrected by applying the 
standard-sample-bracketing approach. The measurement of a sample was bracketed by 
measurements of a ~5 µg/ml Ca solution prepared from a 10,000 µg/g Ca ICP reference 
solution (Ca ICP). Every sample was measured at least four times during a session and the 
mean value used for further calculations. The Ca isotopic composition is reported as δ
44/42
Ca 
in parts per thousand (‰): 
1. δ
44/42
Ca (‰) = [(
44
Ca/
42
Ca)Sample/(
44
Ca/
42
Ca)Reference] – 1 
Further tests confirmed that there is negligible isotope fractionation during purification (<0.01 
‰). Although almost all Sr was removed from the samples during chemical preparation we 
monitored samples for doubly charged Sr (
84
Sr, 
86
Sr and 
88
Sr) that can interfere with the 
measurement of 
42
Ca, 
43
Ca and 
44
Ca, respectively (cf. [27]). We applied several criteria to 
reject data of a single measurement, a single sample and even whole sequences. Following 
Morgan et al. [27] a single measurement was rejected when |δ
44/42
Ca – 2·δ
43/42
Ca|>0.2 ‰. A 
sample measurement (average of 4 to 5 single measurements) was rejected when the 
average intensity was outside a 70 - 130 % intensity window when compared to the average 
intensity of the reference solution from the same batch. A complete sequence was rejected 
when more than one of the measured international reference materials deviated more than 0.2 
‰ from the literature value or the data did not fall along the mass-dependent fractionation line. 
The continuous measurement of international standard materials in the course of this study 
showed that they are in line with published values in the literature. 
1.4 Statistical Analysis 
Quantitative values evaluated in the present diagnostic study were descriptively presented as 
mean and standard deviation (SD), minimum and maximum, as well as quartiles. Nominally 
scaled values were displayed in absolute and percent frequencies. Checking the distribution of 
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quantitative study variables by Kolmogorov-Smirnov test, significant deviations from normality 
were considered. Differences between healthy controls and women with osteoporosis were 
evaluated using Mann-Whitney U-test and were graphically shown in box-whisker plots (Fig. 1). 
Associations between different study variables were measured by nonparametric Spearman 
rank correlation coefficients (Tab. 1 and 2).  
Cut-off values for Ca isotopes in blood and urine were determined by receiver operating 
characteristics (ROC) analyses (Fig. 2) using the Youden criterion. Diagnostic performance 
was measured as sensitivity, specificity and likelihood ratio referenced to the DXA T-score 
values as gold standard. Predictive values were evaluated in relation to the osteoporosis 
prevalence in this study. The central diagnostic meaning of Ca isotopes in combination with 
other influencing factors was assessed by a stepwise logistic regression analysis using 
backward elimination (Tab. 3a, b). 
All tests were performed two sided with a significance level (p) of 5%. An alpha adjustment for 
multiple testing was not applied, and the results were interpreted accordingly. Statistical 
calculations were done using the statistical software IBM SPSS Statistics 25 (SPSS Inc. an IBM 
Company, Chicago, IL). 
2. Results 
2.1 Differences between the osteoporosis and healthy group 
Of the 100 women screened, 20 had low vitamin D levels (≤ 25 nmol/l) and were excluded. The 
remaining 80 subjects were divided into 2 groups based on DXA scans (Table 1): 14 women 
with osteoporosis (≤ -2.5 T-score) and 66 without osteoporosis (> -2.5 T-score) as controls. 
There was no difference in age between groups (p = 0.8). None of the women had fractures in 
the preceeding five years. The Ca intake from milk was significantly different between groups, 
but total Ca was similar (p=0.140, Table 1). As expected, Ca concentrations in blood [Ca]Blood 
were indistinguishable between groups (Tab. 1). There is also no significant isotope difference 
for the feces between the healthy and the osteoporosis group. 
All clinical measures indicative of bone resorption and Ca loss (δ
44/42
CaBlood, δ
44/42
CaUrine ,CRP, 
CTX, CTX/P1NP) and [Ca]Urine were significantly different between the two groups (Table 1 and 
Fig. 1). In particular, Ca isotope values for blood (δ
44/42
CaBlood) and urine (δ
44/42
CaUrine) were 
significantly lower in women suffering from osteoporosis when compared to the control group 
(Fig. 1, Table 1). 
The average DXA T-score value of the healthy and osteoporosis group are -0.98±0.9 and -
3.06±0.8, respectively. For both lumbar spines and femoral neck is similar -0.7±1.7 and -
0.7±1.15. Lumbar spines and femoral neck values are also significantly correlated (R=0.537, 
p<0.0001, Pearson).  
2.2 Correlations of Ca isotopes and DXA to markers of mineral metabolism and bone 
resorption 
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The Ca isotope values of blood (δ
44/42
CaBlood) and urine (δ
44/42
CaUrine) show a clear correlation 
(r=0.765, p<0.001, n=80) to each other and a weak to moderate correlation to the DXA T-
score values (see color coded values in Table 2). High to perfect as well as weak to moderate 
correlations also exist for the δ
44/42
CaBlood and δ
44/42
CaUrine values to [Ca]Urine, 
[Ca]Urine/Creatinine, CRP, CTX, CTX/P1NP and Ca from milk (Tab. 2). The DXA values also 
show weak to moderate correlations to [Ca]Urine, [Ca]Urine/Creatinine and to CTX. 
2.3 ROC determined “cut-off values” for the Ca isotopes in blood and urine for 
women without vitamin D deficiency 
To test the power of the δ
44/42
CaBlood and δ
44/42
CaUrine values in the diagnosis of osteoporosis 
statistically significant and optimized cut off values of -0.85 ‰ and 0.16 ‰ were calculated 
from ROC analyses (Fig. 2, Tables 3a, b). Women with δ
44/42
CaBlood and δ
44/42
CaUrine below 
their specific threshold values were considered to suffer from osteoporosis. Based on the cut-
off values and relative to the DXA defined definition of osteoporosis the sensitivity to diagnose 
osteoporosis from the δ
44/42
CaBlood values was 100% whereas the specificity was calculated to 
be 54.5%. The sensitivity of the δ
44/42
CaUrine values to diagnose osteoporosis was 78.6% and 
specificity was 71.2%. Positive and negative predictive values as well as the related likelihood 
factors are reported in Tab. 3a and 3b. 
In order to further test the predictive power of the Ca isotopes in blood and urine in 
differentiating women with osteoporosis versus those without osteoporosis, all measures with 
p<0.05 from univariate analysis (Table 1) were entered into a stepwise logistic regression. In 
the first step all parameters associated with osteoporosis (δ
44/42
CaBlood, δ
44/42
CaUrine, CRP, 
XTX, CTX/P1NP) were entered into the statistical model. Stepwise exclusion of parameters 
improved the regression model and only δ
44/42
CaBlood remained as the most significant and 
independent predictor for osteoporosis (p<0.001). 
2.4 ROC determined “cut-off values” for the Ca isotope biomarker in blood and 
urine for the entire population 
Repeating the statistical analysis for all women in this study and ignoring their vitamin D status 
(n=100) showed that the best cut off value for δ
44/42
CaBlood values were -0.85 ‰ again which 
predicts osteoporosis with a sensitivity of 94 % and a specificity of 54 %. These values are 
very similar to the values calculated for women without vitamin deficiency. Similarly for urine 
the best cut off δ
44/42
CaUrine value was 0.23 ‰ which predicts an osteoporosis with a sensitivity 
of 72 % and specificity of 67.1 % again comparable to the values in women without Vitamin D 
deficiency. 
3. Discussion 
In accordance with earlier studies [12] [20] [28] our results imply that in osteoporotic women a 
greater proportion of the Ca originates from bones which changed their δ
44/42
CaBlood and 
δ
44/42
CaUrine values without changing their corresponding [Ca]Blood concentration but increasing 
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their [Ca]Urine and [Ca]Urine/Creatinine values (Table. 1). Latter observation indicates a higher 
loss of Ca from the bones in osteoporotic women when compared to the healthy control. 
Statistical analyses show that the ROC optimized sensitivity is 100% corresponding to a 
negative predictive value (NPV) of 100 % for δ
44/42
CaBlood. This indicates that the false-
positive chance of still having osteoporosis although the δ
44/42
CaBlood values is above the ROC 
determined threshold value of -0.85 ‰ corresponds to zero and osteoporosis can be 
excluded. For δ
44/42
CaUrine a NPV of 94 % indicates that the false-positive chance of still 
having osteoporosis although the δ
44/42
CaUrine value is above the threshold value of 0.16 is still 
6 %. The corresponding negative likelihood factors are then 0 and 0.3 for δ
44/42
CaBlood and 
δ
44/42
CaUrine, respectively, which qualifies them as good negative predictive biomarkers for the 
exclusion of osteoporosis. 
However, as a consequence of the low specificity of 55 % the positive predictive value (PPV) 
is only about 32% for δ
44/42
CaBlood and 37% for δ
44/42
CaUrine. This means that subjects having 
δ
44/42
CaBlood and δ
44/42
CaUrine below the corresponding ROC optimized threshold values still 
have a false-negative chance of 30 to 40% of not having osteoporosis. This means the Ca 
isotope biomarker tends to predict more test persons to suffer from osteoporosis than actually 
determined by DXA. 
The apparent discrepancy in predicting osteoporosis between DXA as the gold standard and 
the Ca isotope biomarker may be reconciled taking the different methodological approaches 
into account. Osteoporosis induced bone Ca loss may not affect all bones simultaneously and 
to the same degree. In our study, BMD heterogeneity is demonstrated by the fact that of the 
18 cases, neglecting vitamin D influence, of osteoporosis diagnosed by DXA, five were jointly 
based on the lumbar spine and the femoral neck, while 12 were based on lumbar spine DXA 
alone and one on the femoral neck DXA alone (Fig. 3). Obviously there is a distinct 
heterogeneity in the extent of bone demineralization from one bone to the other, with varying 
degrees of involvement in different bones and in different individuals. This is also supported by 
the observation that most bone fractures occur in women with normal or osteopenic BMD [30] 
and there are a growing number of reports suggesting that many women who fracture have 
BMD higher than that usually associated with osteoporosis ([31] and references therein). 
In contrast the Ca isotope biomarker reflects the current status and dynamics of the 
mineralization/demineralization process of the whole skeleton and not of a single bone. Values 
of δ
44/42
CaBlood and δ
44/42
CaUrine below the threshold value do not necessarily indicate an acute 
osteoporosis but rather a significant contribution of bone Ca to the blood as it is expected for 
osteoporosis and eventual net loss of Ca via the urine. Latter ongoing process may then 
eventually result in a DXA measurable osteoporosis in a later stage. Hence, the Ca isotopes 
measured in blood and urine reflects the net flux of bone Ca and the balance between bone 
mineralization and demineralization whereas DXA determines a distinct BMD status at a 
certain time. In this regard, the Ca isotope biomarker technique and DXA probably 
complement and extend each other. 
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Based on the statistical values of the determined values of sensitivity and specificity in our 
study into we propose that in future individuals who fall below the ROC determined Ca isotope 
biomarker threshold values in blood and urine still undergo DXA examination to determine 
their individual risk of a broken bone. However, based on its high sensitivity to exclude 
osteoporosis in individuals with δ
44/42
CaBlood and δ
44/42
CaBlood values above the threshold limit, 
DXA measurements and exposure to radiation may be avoided. 
3.1 Quantitative Model for Calcium Mineralization and Demineralization in Humans  
The results of our study show that the Ca isotopic composition of blood and urine strongly 
affected by mass-dependent Ca isotope fractionation associated with bone formation (Fig. 1). 
Bone is typically enriched in isotopically light Ca relative to the diet, blood and urine in terms of 
their Ca isotope ratios. With the following model, we demonstrate the quantitative relationship 
between Ca gain and loss in the bones and the measured δ
44/42
CaBlood and δ
44/42
CaUrine values 
(Figs. 4 and 5). For simplicity in the model we focus on the δ
44/42
CaBlood value only. A similar 
model can also be designed for the δ
44/42
CaUrine values. 
The simple two-compartment model for calcium use, transport, and fractionation in humans 
presented here is based on an earlier version by [20] on vertebrates and as well as by [14] on 
humans. It is used to illustrate the quantitative relationship between skeletal Ca balance 
concerning bone mineralization and demineralization and the Ca isotope composition of blood 
(δ
44/42
CaBlood) (Fig. 4 and 5). The parameters in the model are (i) FDiet and δ
44/42
CaDiet, Ca flux 
and isotope composition of dietary calcium entering the body; (ii) FBone-Gain and δ
44/42
CaBone-Gain, 
Ca flux from the blood to the bone and its Ca isotope composition; (iii) FBone-Loss and 
δ
44/42
CaBone-Loss, Ca flux out of the bone and its isotope composition; (iv) Fex and δ
44/42
Caex, Ca 
flux and isotope composition of the excreted Ca from the organism; and (v) the term ΔBone 
reflects the Ca isotope fractionation during Ca precipitation in the bone during mineralization. 
This conceptual model depicted in Fig. 4 results in a differential equation (01) which can be 
rearranged showing the dependency of δ
44/42
CaBlood from the Ca fluxes into (FBone-Gain) and out 
of the bones (FBone-Loss). 
 
2. 
𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑
𝑑𝑡
= 𝐹𝐷𝑖𝑒𝑡 ∙ [𝛿
44
42𝐶𝑎𝐷𝑖𝑒𝑡 − 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑] + 𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠 ∙ [𝛿
44
42𝐶𝑎𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠 − 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑] −
𝐹𝐵𝑜𝑛𝑒−𝐺𝑎𝑖𝑛 ∙ ∆𝐵𝑜𝑛𝑒 − 𝐹𝐸𝑥 ∙ [𝛿
44
42𝐶𝑎𝐸𝑥 − 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑] 
 
In steady state (
𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑
𝑑𝑡
= 0) and assuming that the term 𝐹𝐸𝑥 ∙ [𝛿
44
42𝐶𝑎𝐸𝑥 − 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑] is 
actually close to zero equation (2) can be rearranged: 
 
3. 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑 =  
𝐹𝐷𝑖𝑒𝑡∙𝛿
44
42𝐶𝑎𝐷𝑖𝑒𝑡+𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠∙𝛿
44
42𝐶𝑎𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠−𝐹𝐵𝑜𝑛𝑒−𝐺𝑎𝑖𝑛∙∆𝐵𝑜𝑛𝑒
(𝐹𝐷𝑖𝑒𝑡+𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠)
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Define: 𝑅 =  
𝐹𝐵𝑜𝑛𝑒−𝐺𝑎𝑖𝑛
𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠
 
Then, rearranging of 3.: 
4. 𝛿
44
42𝐶𝑎𝐵𝑙𝑜𝑜𝑑 =  
𝐹𝐷𝑖𝑒𝑡∙𝛿
44
42𝐶𝑎𝐷𝑖𝑒𝑡+𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠∙𝛿
44
42𝐶𝑎𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠−𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠∙𝑅∙∆𝐵𝑜𝑛𝑒
(𝐹𝐷𝑖𝑒𝑡+𝐹𝐵𝑜𝑛𝑒−𝐿𝑜𝑠𝑠)
 
In equation 4 the values for δ
44/42
CaDiet (-0.41 ‰), δ
44/42
CaBone (-1.14 ‰) and ΔBone (-0.3 ‰) are 
already known from our study data (Fig. 1), tables and the discussions above. Furthermore, 
values for the absorbed amount of diet (FDiet) are taken to be 0.15 gCa/day as calculated from 
our data and in accordance with literature values [32]. The two unknowns are the Ca fluxes 
from the blood to the bones (FBone-Gain) and back from the bone to the blood (FBone-Loss). 
However, FBone-Gain can be expressed as a function of FBone-loss (eq. 4) which allows us to 
present the δ
44/42
CaBlood values as a function of the FBone-Loss to FBone-Gain ratio (FBone-Loss / FBone-
Gain) arbitrarily assuming that the daily loss of FBone-Loss is about 1.5 gCa/day [33]. Then equation 
(3) can unambiguously solved as a function of the FBone-Loss/FBone-Gain ratio. 
From Fig. 5 it can be seen that the δ
44/42
CaBlood values decrease as a function of increasing 
FBone-Loss/FBone-Gain values reflecting the increasing contribution of isotopically light Ca from the 
demineralizing bones to the blood (FBone-Loss/FBone-Gain ratio > 1). In contrast increasing Ca fluxes 
from the blood to the bone (FBone-Loss/FBone-Gain ratio > 1) correspond to increasing the 
δ
44/42
CaBlood values. Equilibrium of input and output Ca fluxes (FBone-Loss = FBone-Gain) in the blood 
are reflected by an FBone-Loss/FBone-Gain value of 1 (Fig. 5). 
From our study and model values a δ
44/42
Ca’Blood equilibrium value of about -0.80 ‰ can be 
calculated which is closely corresponding to the average δ
44/42
Ca’Blood  value of the healthy post-
menopausal women of -0.84±0.14 ‰ (Tab. 1). The corresponding calculate FBone-Loss/FBone-Gain 
ratio of  1.3 (Fig. 5) indicate that these women loose about 30% more Ca by bone 
demineralization than they gain by mineralization. The average δ
44/42
Ca’Blood  value of -0.99±0.10  
‰ (Tab. 1) of the osteoporotic post-menopausal women corresponds to a value FBone-Loss/FBone-
Gain ratio of 3.3 (Fig. 5) indicating that these group of women losses 300 % more Ca than they 
gain by bone mineralization. . Note, that these losses just reflect the exchange of Ca between 
bones and blood and are not taking the recycling of Ca in the kidney into account. 
Based on this simple quantitative model, it is made clear that the δ
44/40
CaBlood value in humans 
will provide a quantitative indication of the relative rates of mineral formation (FBone-Gain) and 
mineral dissolution (FBone-Loss). Organisms experiencing FBone-Loss/FBone-Gain value of > 1 reflecting 
bone demineralization should have δ
44/40
CaBlood values that are below the equilibrium value. 
Whereas organisms experiencing FBone-Loss/FBone-Gain values < 1 reflecting mineralization are 
characterized by δ
44/40
CaBlood value values above the equilibrium value. 
4. Limitations of our study 
 We were unable to achieve the target number of women with osteoporosis as estimated 
from initial calculations. 
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 A study examining a larger population of women, and ideally with repeat measurements of 
Ca isotope fractionation in a longitudinal follow-up study design would be recommended. 
 Our study does not examine the association of Ca isotope measurements against fracture 
outcomes, and this would be an important aspect for future study. 
 Our study population was also limited to post-menopausal women only, and future studies 
must include other groups too. 
 Other factors may potentially influence the Ca isotope composition, such as changes in the 
amount or type of diet, changes in the rates of renal Ca reabsorption as expected in renal 
impairment and the rates of Ca turnover require further investigation. 
 The effects of anti-resorptive therapy such as bisphosphonates or denosuamb on changes 
in BMD will also be the subject of future studies. 
5. Summary of the results and discussion 
1. Bone resorption that leads to a net loss of bone Ca in women with osteoporosis cause a 
decrease in the Ca isotope values of blood and urine. 
2. Ca isotope ratios measured in blood (δ
44/42
CaBlood) and urine (δ
44/42
CaUrine) reflects the Ca 
balance of the whole skeleton rather than of individual bones. 
3. Ca isotopes in blood and urine correlated highly significantly with each other and with the 
corresponding DXA measurements. Diagnostic sensitivity for the δ
44/42
CaBlood values was 
100% and for the δ
44/42
CaUrine values 72%.  
4. ROC optimized cut-off values (δ
44/42
CaBlood < -0.85, δ
44/42
CaUrine < 0.16) significantly 
discriminated individuals with and without osteoporosis. 
5. Logistic regression analysis showed that the Ca isotope composition of blood 
(δ
44/42
CaBlood) was the strongest and independent biomarker for osteoporosis and the 
addition of other clinical parameters did not improve its diagnostic power. 
6. The apparently low specificity of 55 % of Ca isotopes in blood to predict osteoporosis on 
DXA is inherent to the methodological approaches in measuring bone mineralization by 
DXA and the Ca isotope biomarker. 
Acknowledgement 
AE acknowledges the support of the Helmholtz association and its “Helmholtz Impuls and 
Vernetzungsfond”. The GEOMAR Research Centre for Marine Sciences Kiel is gratefully 
acknowledged for financial support. RS is supported by a fellowship from the National Institute 
for Health Research. Results are partly patent protected under the code numbers DE10 2018 
214 660 for Germany and EP 18191474 for Europe. We thank the two anonymous reviewers for 
their careful reviews. Their comments and suggestions helped to significantly improve the 
manuscript. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
13 
 
Tables: 
Table 1: Comparison of women without and with osteoporosis 
Characteristics 
Women without 
osteoporosis 
n = 66 
Women with 
osteoporosis 
n = 14 
p 
Age 69.7±5.4 69.9±5.5 0.800 
Total Ca (g/day): 0.99±0.28 1.15±0.39 0.140 
Ca from milk (g/day) 0.42±0.8 0.53±0.20 0.005 
[Ca]Blood (mmol/l) 2.39±0.10 2.42±0.10 0.410 
[Ca]Urine (mmol/l) 1.96±1.39 2.58±1.26 0.042 
[Ca]Urine/Creatinine 
([mmol
.
dl]/[l
.
mg]) 
0.031±0.04 0.048±0.09 0.014 
[Ca]Feces (mmol/l) -0.31±0.09 -0.33±0.11 0.598 
DXA T-scores -0.98±0.9 -3.06±0.8 --- 
δ
44/42
CaBlood (‰) -0.84±0.14 -0.99±0.10 <0.001 
δ
44/42
CaUrine (‰) 0.35±0.33 0.10±0.21 0.004 
CRP (hs) 2.57±1.95 1.65±0.24 0.024 
CTX (µg/l) 0.46±0.17 0.57±0.06 0.045 
CTX/P1NP (µg
2
/l
2
) 0.009±0.002 0.01±0.002 0.020 
Note: all reported uncertainties are 1 SD. 
Table 2: Pairwise Spearman rank correlations between parameters of 
mineral metabolism 
Spearman rank 
correlation coefficient R 
and p-value 
δ
44/42
CaBlood [‰] 
δ
44/42
CaUrine 
[‰] 
DXA T scores 
R 
(p) 
δ
44/42
CaBlood (‰) --- 
0.765 
(<0.001) 
0.316 
(0.004) 
δ
44/42
CaUrine (‰) 
0.765 
(<0.001) 
--- 
0.245 
(0.028) 
[Ca]Blood (mmol/l) 
-0.09 
(0.938) 
-0.018 
(0.876) 
-0.004 
(0.971 
[Ca]Urine(mmol/l) 
-0.489 
(0.001) 
-0.606 
(0.001) 
-0.272 
(0.015) 
[Ca]Urine/Creatinine 
-0.531 
(0.001) 
-0.808 
(0.001) 
-0.284 
(0.011) 
CRP 
0.283 
(0.011) 
0.192 
(0.088) 
0.132 
CTX 
0.457 
(-0.084) 
0.073 
(0.202) 
-0.235 
(0.036) 
CTX/P1NP 
-0.242 
(0.031) 
-0.232 
(0.039) 
-0.174 
(0.122) 
Ca from milk (g/day)  
-0.272 
(0.015) 
-0.287 
(0.010) 
-0.034 
(0.762) 
Total Calcium (g/day): 
-0.134 
(0.236) 
-0.166 
(0.140) 
0.002 
(0.984) 
 
 
No to low ,0 ≤ R ≤ │0.2│ 
Weak to moderate, │0.2│ ≤ R ≤ │0.5│ 
Clear correlation, │0.5│ ≤ R ≤ │0.8│ 
High to perfect correlation, │0.8│ ≤ R ≤ │1│ 
Note: Color coding emphasizes the degree of statistical significance of the correlations. 
The δ
44/42
CaBlood- and δ
44/42
CaUrine-values as well as DXA T-scores are compared 
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(Spearman correlation) with parameters of mineral metabolism. Only parameters where 
at least one pair showed statistical significance are shown. 
  
Table 3a: Criteria to assess the diagnostic power of Ca isotopes in urine 
(δ
44/42
CaUrine) 
Serum δ
44/42
Ca: 
Osteoporosis without 
Vitamin D deficiency 
Osteoporosis without Vitamin D 
deficiency 
Total no yes 
no (> -0,8475) 36 (45,0%) 0 (0%) 36 (45%) 
yes (≤ -0,8475) 30 (37,5%) 14 (17,5%) 44 (55%) 
Total 66 (82,5%) 14 (17,5%) 80 (100%) 
 
Quality criteria Value 
95%-CI 
lower limit upper limit 
Prevalence  17.50% 9.91% 27.62% 
Sensitivity 100.00% 76.84% 100.00% 
Specificity 54.55% 41.81% 66.86% 
Positive predictive value 31.82% 18.61% 47.58% 
Negative predictive value 100.00% 90.26% 100.00% 
Positive likelihood ratio (LR+) 2.20 1.69 2.87 
Negative Likelihood ratio (LR-) 0 0 0 
Correct classification rate 62.50% 50.96% 73.08% 
Youden-Index 54.55% 42.53% 66.56% 
LR+ = Sensitivity/(1-Specificity); LR- = (1-Sensitivity)/Specificity 
 
Table 3b:  Criteria to assess of diagnostic power of Ca isotopes in urine 
(δ
44/42
CaUrine) 
Urine δ
44/42
Ca: 
Osteoporosis without 
Vitamin D deficiency 
Osteoporosis without Vitamin D 
deficiency 
Total no yes 
no (> 0,1638) 47 (58,8%) 3 (3,8%) 50 (62,5%) 
yes (≤ -0, 1638) 19 (23,8%) 11 (13,8%) 30 (37,5%) 
Total 66 (82,5%) 14 (17,5%) 80 (100%) 
 
Quality criteria Value 
95%-CI 
lower limit upper limit 
Prevalence  17.50% 9.91% 27.62% 
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Sensitivity 78.57% 49.20% 95.34% 
Specificity 71.21% 58.75% 81.70% 
Positive predictive value 36.67% 19.93% 56.14% 
Negative predictive value 94.00% 83.45% 98.75% 
Positive likelihood ratio (LR+) 2.73 1.71 4.36 
Negative Likelihood ratio (LR-) 0.30 0.11 0.83 
Correct classification rate 72.50% 61.38% 81.90% 
Youden-Index 49.78% 25.67% 73.89% 
LR+ = Sensitivity/(1-Specificity); LR- = (1-Sensitivity)/Specificity 
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Fig. 1: 
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Fig. 2: 
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Fig. 3: 
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Fig. 4: 
 
 
 
 
Fig. 5  
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Figure captions: 
Fig 1: Ca isotope box plot values in women with (n=14) and without osteoporosis (n=66). Calcium isotope 
values in blood and serum are box plotted with their corresponding mean values diet, feces and 
calculated mean value for bone (see details in the text). There is no statistical difference in Ca isotope 
values between the two groups concerning the diet (p=0.300) or the feces (p=0.600). However, women 
suffering from DXA diagnosed osteoporosis showed significantly lower δ
44/42
CaBlood (p<0.001) and 
δ
44/42
CaUrine (p=0.004) values than those not suffering from osteoporosis. Boxes mark the 25% and 75% 
quartile, lines mark the median and squares mark the mean value. Diamonds mark outliers and stars 
mark the 1% and 99% limit of the data. 
Fig. 2: ROC curves for Ca isotope values in blood and urine for the prediction of osteoporosis. The best 
cut off in blood for δ
44/42
CaBlood values was found at about -0.85 which predicts osteoporosis (without 
vitamin d deficiency) for values lower or equal with a sensitivity of 100 % and a specificity of 54.5 %. 
The best cut off value for Ca isotopes in urine for δ
44/42
CaUrine was found at 0.16 which predicts 
osteoporosis (without vitamin d deficiency) for values lower or equal to a sensitivity of 78.6 % and 
specificity of 71.2 %. Table 3 presents the correctness of prediction using this cut off. 
Fig 3: Correlations between DXA T-scores from femoral neck and lumbar spine for all 100 subjects. 
Broken horizontal and vertical lines represent T-score threshold values of -2.5 for the diagnosis of 
osteoporosis. DXA diagnosed osteoporosis and vitamin D deficiencies are marked. Osteoporosis was 
diagnosed in in total of 18 cases. Only in 5 cases osteoporosis was diagnosed based on T-score values 
of both, femoral neck and lumbar spine (marked area). Only in one case osteoporosis is based on the 
femoral neck alone and in 12 cases lumbar spines alone indicated osteoporosis. 
 
Fig. 4: Simplified transport model for Ca isotopes between blood and bones in humans. In this model, 
there is no calcium isotopic fractionation associated with absorption, excretion of dietary calcium and 
dissolution of bones. Calcium incorporated into bone is derived from the blood, and there is a 
fractionation (ΔBone) associated with the formation of bones.  
 
Fig. 5: In this diagram the blood Ca isotope values are shown as a function of the FBone-Loss/FBone-Gain ratios. 
An FBone-Loss/FBone-Gain of 1 corresponds to the equilibrium value at which FBone-Loss equals FBone-Gain. Above 
the equilibrium value Ca isotope values indicate a net gain of Ca from the blood and below 1 Ca isotopes 
indicate a net loss of Ca from the bones. The blue point marks the average Ca isotope composition of 
blood (δ
44/42
CaBlood) for the healthy post-menopausal women (FBone-Loss/FBone-Gain 1.3) and the red point 
marks the average composition of the osteoporotic post-menopausal women (FBone-Loss/FBone-Gain 3.3). 
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